Alembic Pharmaceuticals receives USFDA final approval for Pirfenidone tablets
The tablets have an estimated market size of US $ 548 million for twelve months ending December 2021 according to IQVIA
The tablets have an estimated market size of US $ 548 million for twelve months ending December 2021 according to IQVIA
Ulcerative colitis is a chronic, immune-mediated inflammatory bowel disease that can lead to substantial burden and often disability among patients
A seasoned professional, he will lead the strategy and business operations of Cadila’s branded prescriptions pharma business
This ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies
According to the brokerage, as the pandemic has receded, the past exceptional growth in acute therapies may not be repeated (stellar double-digit growth for anti-infectives coming down)
While Pregabalin will be manufactured at the Aurangabad facility, Iloperidone will be manufactured at the Goa facility
Docosanol Cream, 10% (OTC) has an estimated market size of US$60 million for twelve months ending December 2021 according to IQVIA
The USFDA approval in AS marks the fifth indication for Rinvoq in chronic immune-mediated diseases
Peak Proteins has collaborated closely with Sygnature Discovery for several years and together the companies have supported a number of integrated drug discovery programmes
Clobetasol Propionate Foam, 0.05% has an estimated market size of US $ IO million for twelve months ending Dec 2021 according to IQVIA
Subscribe To Our Newsletter & Stay Updated